Biphasic firing response of nucleus accumbens neurons elicited by THPB-18 and its correlation with DA receptor subtypes

Acta Pharmacologica Sinica

Volumn 25, Issue 12, 2004, Pages 1597-1605

  Fu, Yu ^a,b,c   Zhu, Zi Tao ^a,d   Zhu, Xing Zu ^a   Jin, Guo Zhang ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c University of Texas Medical Branch School of Medicine   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Berberine; Dopamine D1 receptors; Dopamine D2 receptors; Nucleus accumbens

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BERBINE DERIVATIVE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR; OXIDOPAMINE; QUINPIROLE; RECEPTOR SUBTYPE; SPIPERONE; STEPHOLIDINE; TETRAHYDROPROTOBERBERINE 18; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; IONTOPHORESIS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; APOMORPHINE; BERBERINE ALKALOIDS; MALE; NEURONS; NUCLEUS ACCUMBENS; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SPIPERONE; VENTRAL TEGMENTAL AREA;

EID: 10344266989     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jin GZ. (-)-Tetrahydropalmatine and its analogues as new dopamine receptor antagonists. Trends Pharmacol Sci 1987; 8: 81-2.
2. Jin GZ, Zhu ZT, Fu Y. (-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions. Trends Pharmacol Sci 2002; 23: 4-7.
3. Huang KX, Sun BC, Jin GZ. (-)-Stepholidine: a dopamine receptor antagonist shows agonistic effect on rotational behavior in 6-hydroxydopamine- lesioned rats. Acta Pharmacol Sin 1992; 13: 17-22.
4. Dong ZJ, Guo X, Chen LJ, Han YF, Jin GZ. Dual actions of (-)-stepholidine on the dopamine receptor-mediated adenylate cyclase activity in rat corpus striatum. Life Sci 1997; 61: 465-72.
5. Zhang XX, Sun BC, Jin GZ. Atypical neuroleptic properties of l-stepholidine - electrophysiological and behavioral studies. Sci China C Life Sci 1997; 40: 531-8.
6. Sun BC, Jin GZ. Effects of (-)-stepholidine on firing activity of dopamine neurons in ventral tegmental area of rats. Acta Pharmacol Sin 1992; 13: 395-9.
7. Zhu ZT, Fu Y, Hu GY, Jin GZ. Electrophysiological study on biphasic firing activity elicited by D1 agonistic - D2 antagonistic action. Acta Physiol Sin 2000; 52: 123-30.
8. Chen LJ, Xi Y, Pang DW, Zhou QT, Jin GZ. Effect of (+/-) 12-chloroscoulerine on brain dopamine receptors. Acta Pharmacol Sin 1996; 17: 185-9.
9. Chen LJ, Zhou QT, Dong ZJ, Yu LP, Jin GZ. Comparison of 12-chloroscoulerine enantiomers on animal behavior to dopamine receptors. Acta Pharmacol Sin 1999; 20: 884-8.
10. Jin XL, Shao Y, Wang MJ, Chen LJ, Jin GZ. Tetrahydroprotoberberines inhibit lipid peroxidation and scavenge hydroxyl free radicals. Acta Pharmacol Sin 2000; 21: 477-80.
11. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sidney: Academic Press; 1982.
12. Zhang XX, Liu J, Fu Y, Hu GY, Jin GZ. Action sites of rotation and unit firing induced by l-stepholidine and DA agonists in basal ganglia of 6-OHDA-lesioned rats. Acta Pharmacol Sin 1999; 20: 979-86.
13. Sun BC, Zhang XX, Jin GZ. (-)-Stepholidine acts as a D1 partial agonist on firing activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine-lesioned rats. Life Sci 1996; 59: 299-306.
14. White FJ, Wang RY. Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens. J Neurosci 1986; 6: 274-80.
15. Moal ML. Mesocorticolimic dopaminergic neurons: functional and regulatory roles. In: Bloom FE, editor. Psychopharma-cology: The 4th generation of progress. New York: Raven Press, 1995. p 283-93.
16. Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 1991; 148: 1474-86.
17. Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 1997; 385: 634-6.
18. Yang CR, Seamans JK, Gorelova N. Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex. Neuropsychopharmacology 1999; 21: 161-94.
19. Castner SA, Williams GV, Goldman-Rakic PS. Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. Science 2000; 287: 2020-2.
20. Zhu ZT, Fu Y, Hu GY, Jin GZ. Modulation of medical prefrontal cortical D1 receptors on the excitatory firing activity of nucleus accumbens neurons elicited by (-)-stepholidine. Life Sci 2000; 67: 1265-74.
21. Pucak ML, Grace AA. Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. J Pharmacol Exp Ther 1994; 271: 1181-92.
22. Roth RH, Elsworth JD. Biochemical pharmacology of midbrain dopamine neurons. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995. p 227-44.
23. Gonon F, Sundstrom L. Excitatory effects of dopamine released by impulse flow in the rat nucleus accumbens in vivo. Neuroscience 1996; 75: 13-8.
24. Montaron MF, Deniau JM, Menetrey A, Glowinski J, Thierry AM. Prefrontal cortex inputs of the nucleus accumbens-nigro-thalamic circuit. Neuroscience 1996; 71: 371-82.
25. Lidow MS, Williams GV, Goldman-Rakic PS. The cerebral cortex: a case for a common site of action of antipsychotics. Trends Pharmacol Sci 1998; 19: 136-40.
26. Grace AA, Moore H, O'Donnell P. The modulation of corticoaccumbens transmission by limbic afferents and dopamine: a model for the pathophysiology of schizophrenia. Adv Pharmacol 1998; 42: 721-4.